• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-615-3p 通过其潜在靶基因 CELF2 促进胃癌的增殖、迁移,抑制凋亡。

miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.

机构信息

The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Biomed Pharmacother. 2018 May;101:406-413. doi: 10.1016/j.biopha.2018.02.104. Epub 2018 Mar 22.

DOI:10.1016/j.biopha.2018.02.104
PMID:29501762
Abstract

Gastric cancer incidence is relatively higher in China than that in developed countries; however, molecular mechanisms considering the initiation and progression of gastric cancer are still unclear. For decades, numerous microRNAs have been found to regulate a wide range of biological functions in gastric cancer. However, the oncogenic function of miR-615-3p in gastric cancer has not been reported to date. With the help of gene and microRNA chips in 10 patients, we were able to screen differential expressed genes and microRNAs compared with normal gastric tissues. After that, online bioinformatics analysis tools were used to predict microRNAs' potential targets. As a result, miR-615-3p and its potential target, CELF2, were selected for further experiments. QRT-PCR and western blot results indicated the aberrant high expression of miR-615-3p and low expression of CELF2 in gastric cancer both in vivo and in vitro. Moreover, miR-615-3p expression correlated to T and M stage. Up regulation of miR-615-3p inhibited the apoptosis, promoted proliferation and migration and led to the down-regulation of CELF2. Meanwhile, down-regulation of miR-615-3p resulted in anti-tumor effects. Immunochemistry staining of CELF2 showed its association with T, N and M stage. In addition, overexpression of CELF2 could reverse miR-615-3p's oncogenic functions stated before. These findings indicate that miR-615-3p promotes gastric cancer proliferation and migration by suppressing CELF2 expression for the first time, providing clues for future clinical practices.

摘要

在中国,胃癌的发病率相对高于发达国家;然而,考虑到胃癌的发生和发展的分子机制仍不清楚。几十年来,已经发现许多 microRNAs 可以调节胃癌中的广泛的生物学功能。然而,miR-615-3p 在胃癌中的致癌功能迄今尚未报道。在 10 名患者的基因和 microRNA 芯片的帮助下,我们能够筛选出与正常胃组织相比差异表达的基因和 microRNAs。之后,使用在线生物信息学分析工具来预测 microRNAs 的潜在靶标。结果,选择 miR-615-3p 和其潜在靶标 CELF2 进行进一步实验。QRT-PCR 和 western blot 结果表明,miR-615-3p 在体内和体外的胃癌中表达异常升高,而 CELF2 表达降低。此外,miR-615-3p 的表达与 T 和 M 期相关。miR-615-3p 的上调抑制了细胞凋亡,促进了增殖和迁移,并导致 CELF2 的下调。同时,下调 miR-615-3p 则产生抗肿瘤作用。CELF2 的免疫组织化学染色表明其与 T、N 和 M 期有关。此外,CELF2 的过表达可以逆转之前提到的 miR-615-3p 的致癌作用。这些发现表明,miR-615-3p 通过抑制 CELF2 的表达首次促进胃癌的增殖和迁移,为未来的临床实践提供了线索。

相似文献

1
miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.miR-615-3p 通过其潜在靶基因 CELF2 促进胃癌的增殖、迁移,抑制凋亡。
Biomed Pharmacother. 2018 May;101:406-413. doi: 10.1016/j.biopha.2018.02.104. Epub 2018 Mar 22.
2
Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.微小RNA-193-3p的下调通过调控PTEN基因抑制人胃癌的肿瘤增殖、迁移和化疗耐药性。
Tumour Biol. 2016 Jul;37(7):8941-9. doi: 10.1007/s13277-015-4727-x. Epub 2016 Jan 11.
3
MicroRNA-509-3p Inhibits Cancer Cell Proliferation and Migration via Upregulation of XIAP in Gastric Cancer Cells.微小RNA-509-3p通过上调胃癌细胞中的X连锁凋亡抑制蛋白来抑制癌细胞增殖和迁移。
Oncol Res. 2017 Mar 13;25(3):455-461. doi: 10.3727/096504016X14747283032017. Epub 2016 Sep 30.
4
Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.miR-95-3p的下调通过靶向CELF2抑制胶质瘤细胞的增殖、侵袭并促进其凋亡。
Int J Oncol. 2015 Sep;47(3):1025-33. doi: 10.3892/ijo.2015.3080. Epub 2015 Jul 10.
5
miR-363-3p induces EMT via the Wnt/β-catenin pathway in glioma cells by targeting CELF2.miR-363-3p 通过靶向 CELF2 诱导胶质瘤细胞中的 EMT 发生,该过程涉及 Wnt/β-catenin 通路。
J Cell Mol Med. 2021 Nov;25(22):10418-10429. doi: 10.1111/jcmm.16970. Epub 2021 Oct 12.
6
CircPTK2 inhibits the tumorigenesis and metastasis of gastric cancer by sponging miR-134-5p and activating CELF2/PTEN signaling.环状 RNA PTK2 通过海绵吸附 miR-134-5p 并激活 CELF2/PTEN 信号通路抑制胃癌的发生和转移。
Pathol Res Pract. 2021 Nov;227:153615. doi: 10.1016/j.prp.2021.153615. Epub 2021 Sep 14.
7
LncRNA RHPN1-AS1 promotes the progression of nasopharyngeal carcinoma by targeting CELF2 expression.长链非编码 RNA RHPN1-AS1 通过靶向 CELF2 表达促进鼻咽癌的进展。
Exp Mol Pathol. 2021 Oct;122:104671. doi: 10.1016/j.yexmp.2021.104671. Epub 2021 Aug 4.
8
miR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6.miR-24-3p通过过氧化物酶体增殖物激活受体6调节胃黏膜病变进展并抑制N87细胞的增殖和侵袭能力。
Dig Dis Sci. 2016 Dec;61(12):3486-3497. doi: 10.1007/s10620-016-4309-9. Epub 2016 Oct 14.
9
MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.miR-210-3p 通过靶向 CELF2 促进肺鳞癌的进展PI3K/AKT 通路。
Med Oncol. 2022 Aug 16;39(11):161. doi: 10.1007/s12032-022-01752-6.
10
Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.miRNA-27b-3p 的下调通过异常的 DNA 甲基化靶向 GSPT1 促进胃癌细胞的恶性行为。
Biomed Pharmacother. 2019 Nov;119:109417. doi: 10.1016/j.biopha.2019.109417. Epub 2019 Sep 17.

引用本文的文献

1
Mir-615-3p promotes osteosarcoma progression via the SESN2/AMPK/mTOR pathway.微小RNA-615-3p通过SESN2/AMPK/mTOR途径促进骨肉瘤进展。
Cancer Cell Int. 2024 Dec 19;24(1):411. doi: 10.1186/s12935-024-03604-x.
2
A comprehensive in silico investigation into the pathogenic SNPs in the RTEL1 gene and their biological consequences.全面的 RTEL1 基因致病变异 SNP 的计算机分析及其生物学后果。
PLoS One. 2024 Sep 6;19(9):e0309713. doi: 10.1371/journal.pone.0309713. eCollection 2024.
3
Loss of CELF2 promotes skin tumorigenesis and increases drug resistance.
CELF2的缺失促进皮肤肿瘤发生并增加耐药性。
Int J Dermatol. 2025 Jan;64(1):101-110. doi: 10.1111/ijd.17295. Epub 2024 Jun 17.
4
Evaluating the pro-survival potential of apoptotic bodies derived from 2D- and 3D- cultured adipose stem cells in ischaemic flaps.评估来源于 2D 和 3D 培养脂肪干细胞的凋亡小体在缺血皮瓣中的促生存潜力。
J Nanobiotechnology. 2024 Jun 14;22(1):333. doi: 10.1186/s12951-024-02533-1.
5
UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.UBE2C:通过生物信息学分析发现的一种泛癌诊断和预后生物标志物。
Cancer Rep (Hoboken). 2024 Apr;7(4):e2032. doi: 10.1002/cnr2.2032.
6
Elucidating the molecular basis of ATP-induced cell death in breast cancer: Construction of a robust prognostic model.阐明乳腺癌中ATP诱导的细胞死亡的分子基础:构建一个可靠的预后模型。
World J Clin Oncol. 2024 Feb 24;15(2):208-242. doi: 10.5306/wjco.v15.i2.208.
7
Integrated co-expression analysis of regulatory elements (miRNA, lncRNA, and TFs) in bovine monocytes induced by Str. uberis.牛单核细胞中 Str. uberis 诱导的调控元件(miRNA、lncRNA 和 TFs)的综合共表达分析。
Sci Rep. 2023 Sep 12;13(1):15076. doi: 10.1038/s41598-023-42067-4.
8
Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review).CELF2 在铁死亡中的作用:癌症治疗的潜在靶点(综述)。
Int J Mol Med. 2023 Oct;52(4). doi: 10.3892/ijmm.2023.5291. Epub 2023 Aug 18.
9
Lymphatic Dissemination in Prostate Cancer: Features of the Transcriptomic Profile and Prognostic Models.前列腺癌中的淋巴转移:转录组特征及预后模型。
Int J Mol Sci. 2023 Jan 26;24(3):2418. doi: 10.3390/ijms24032418.
10
CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma.CD44v3 是胃癌侵袭性癌症干细胞的标志物,可促进转移。
Gastric Cancer. 2023 Mar;26(2):234-249. doi: 10.1007/s10120-022-01357-y. Epub 2022 Dec 18.